SCYX
Scynexis Inc
NASDAQ: SCYX · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$0.93
-0.46% today
Updated 2026-04-30
Market cap
$78.31M
P/E ratio
—
P/S ratio
3.80x
EPS (TTM)
$-0.17
Dividend yield
—
52W range
$1 – $1
Volume
0.6M
Scynexis Inc (SCYX) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $16.84M | $16.86M | $1.26M | $257000.00 | $257000.00 | $257000.00 | $257000.00 | $121000.00 | $12.05M | $13.16M | $5.09M | $140.14M | $3.75M | $20.60M |
| Revenue growth (YoY) | — | +0.1% | -92.5% | -79.5% | +0.0% | +0.0% | +0.0% | -52.9% | +9858.7% | +9.2% | -61.3% | +2652.7% | -97.3% | +449.9% |
| Cost of revenue | $14.36M | $16.30M | $15.45M | $28.55M | $28.05M | $26.54M | $0.00 | — | $303000.00 | $312000.00 | $628000.00 | $15.62M | $0.00 | — |
| Gross profit | $2.47M | $552000.00 | $-14.19M | $257000.00 | $257000.00 | $257000.00 | $257000.00 | $121000.00 | $-303000.00 | $12.85M | $4.46M | $124.52M | $3.75M | $20.60M |
| Gross margin | 14.7% | 3.3% | -1129.8% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | -2.5% | 97.6% | 87.7% | 88.9% | 100.0% | 100.0% |
| R&D | $8.93M | $4.36M | $8.29M | $16.44M | $20.08M | $18.33M | $21.56M | $38.39M | $36.52M | $23.77M | $27.26M | $30.93M | $26.41M | $22.28M |
| SG&A | $13.67M | $8.74M | $7.57M | $12.17M | $8.00M | $8.25M | $8.68M | $10.65M | $14.63M | $49.92M | $62.96M | $33.29M | $14.46M | $14.39M |
| Operating income | $-7.78M | $-7.20M | $-14.65M | $-28.35M | $-27.82M | $-26.32M | $-29.98M | $-48.92M | $-51.15M | $-60.84M | $-85.76M | $72.67M | $-37.12M | $-16.07M |
| Operating margin | -46.2% | -42.7% | -1166.2% | -11030.7% | -10823.7% | -10241.2% | -11666.5% | -40430.6% | -424.5% | -462.2% | -1684.5% | 51.9% | -990.8% | -78.0% |
| EBITDA | $-9.71M | $-13.76M | $-2.19M | $-27.90M | $-29.51M | $-23.16M | $-17.10M | $-51.27M | $-55.65M | $-32.91M | $-59.91M | $70.89M | $-18.58M | $-16.07M |
| EBITDA margin | -57.7% | -81.6% | -174.6% | -10856.8% | -11483.3% | -9013.2% | -6652.5% | -42370.2% | -461.8% | -250.1% | -1176.8% | 50.6% | -496.1% | -78.0% |
| EBIT | $-11.20M | $-15.09M | $-3.43M | $-28.35M | $-29.54M | $-23.20M | $-17.15M | $-51.55M | $-55.95M | $-33.29M | $-60.72M | $70.31M | $-20.31M | — |
| Interest expense | $972000.00 | $11.89M | $803000.00 | $11000.00 | $451000.00 | $1.85M | $2.05M | $2.16M | $1.18M | $3.96M | $6.79M | $6.12M | $2.55M | $485000.00 |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-11.48M | $-30.46M | $-4.23M | $-32.62M | $-29.99M | $-25.06M | $-12.47M | $-53.71M | $-55.19M | $-32.87M | $-62.81M | $67.04M | $-21.29M | $-8.61M |
| Net income growth (YoY) | — | -165.4% | +86.1% | -670.5% | +8.1% | +16.4% | +50.2% | -330.8% | -2.7% | +40.4% | -91.1% | +206.7% | -131.8% | +59.6% |
| Profit margin | -68.2% | -180.7% | -337.1% | -12693.8% | -11668.9% | -9751.0% | -4851.4% | -44388.4% | -458.0% | -249.7% | -1233.7% | 47.8% | -568.3% | -41.8% |